Cigna Corp. fell$. 25 or. 4 percent, to $69.41. Humana Inc. rose$. 27 or. 3 percent, to $83.87. UnitedHealth Group fell$. 18 or. 3 percent, to $65.50.
Allergan fell$. 40 or. 4 percent, to $101.09. Baxter International Inc. fell$. 49 or. 7 percent, to $70.39. Boston Scientific Corp. fell$. 03 or. 3 percent, to $9.51.
Snow Capital identified the potential in hospital shares early on and has holdings in Community Health Systems Inc and Health Management Associates Inc.. Since the start of the year, shares of the largest publicly traded hospital chain, HCA Holdings Inc, are up 34 percent, while No. 2 Community Health has climbed 71 percent.
Allergan rose$. 01 or percent, to $101.49. Baxter International Inc. rose$. 15 or. 2 percent, to $70.88. Boston Scientific Corp. fell$. 10 or 1.0 percent, to $9.54.
Cigna Corp. rose $1.38 or 2.0 percent, to $69.66. Humana Inc. rose $1.36 or 1.7 percent, to $83.60. UnitedHealth Group rose $1.31 or 2.0 percent, to $65.68.
WASHINGTON, June 18- Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months.
WASHINGTON, June 18- Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months.
Among the stock activity stories for Tuesday, June 18, from AP Business News:. _ Shares of Medtronic Inc. slipped, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft.
Cigna Corp. rose $1.09 or 1.6 percent, to $69.37. Humana Inc. rose $1.17 or 1.4 percent, to $83.41. UnitedHealth Group rose $1.17 or 1.8 percent, to $65.54.
Allergan fell$. 45 or. 4 percent, to $101.03. Baxter International Inc. rose$. 06 or. 1 percent, to $70.79. Boston Scientific Corp. fell$. 09 or. 9 percent, to $9.55.
Shares of Medtronic Inc. slipped Tuesday, a day after the medical device maker announced findings from independent reviews of studies of its Infuse bone graft.
Cigna Corp. fell$. 04 or. 1 percent, to $68.25. Humana Inc. rose$. 19 or. 2 percent, to $82.43. UnitedHealth Group rose$. 33 or. 5 percent, to $64.70.
Allergan fell$. 41 or. 4 percent, to $101.07. Baxter International Inc. rose$. 11 or. 2 percent, to $70.84. St. Jude Medical Inc. fell$. 03 or. 1 percent, to $45.63.
Cigna Corp. rose$. 12 or. 2 percent, to $68.28. Humana Inc. rose $1.31 or 1.6 percent, to $82.24. UnitedHealth Group rose$. 57 or. 9 percent, to $64.37.
Allergan rose$. 34 or. 3 percent, to $101.48. Baxter International Inc. rose$. 13 or. 2 percent, to $70.73. Boston Scientific Corp. rose$. 13 or 1.4 percent, to $9.64.
SANTA FE, N.M.-- More than 30,000 state and local government workers face a 15 percent increase for their health care insurance starting next month, but it could be only the beginning of higher costs as New Mexico's self-insurance program digs out of a financial hole.
NEW YORK-- BioScrip Inc. plans to expand its drug infusion business with a $223 million acquisition of CarePoint, which administers drugs to patients in their homes and other locations outside of hospitals. BioScrip expects about $160 million in annual revenue from CarePoint, while BioScrip posted $663 million in revenue in 2012..
Allergan rose$. 72 or. 7 percent, to $101.86. Baxter International Inc. rose$. 09 or. 1 percent, to $70.69. Boston Scientific Corp. rose$. 20 or 2.1 percent, to $9.71.
Cigna Corp. rose$. 54 or. 8 percent, to $68.70. Humana Inc. rose $1.09 or 1.3 percent, to $82.02. UnitedHealth Group rose $1.34 or 2.1 percent, to $65.14.
Allergan rose$. 99 or 1.0 percent, to $102.13. Baxter International Inc. rose$. 39 or. 6 percent, to $70.99. Medtronic rose$. 39 or. 7 percent, to $53.31.
No reason has been given yet for the departure of founder and executive chairman George Zimmer, reports CNBC's Courtney Reagan. Zimmer has long been the face of the company.
Wednesday, 19 Jun 2013 | 10:52 AM ETCNBC's Rick Santelli, explains why he hears 'crickets" when he asks questions about Fed Chairman Bernanke's policies. "Enough is enough," he rants.
Wednesday, 19 Jun 2013 | 11:36 AM ETAre reporters lobbing "softball" questions at the Fed chairman? CNBC's Rick Santelli and the Wall Street Journal's Jon Hilsenrath, debate whether the economy continues to need quantitative easing. I'm trying to inform the public about what the Fed is up to, says Hilsenrath.